Chamc

CHA Health Systems is a global network consisting of leading healthcare organizations, academic and research institutions and biomedical ventures with about 8000 employees worldwide. Our vision is to be the world's number one biomedical group by translating our groundbreaking research findings into impactful medical practices and applications that nourish the communities we serve. CHA Health Systems began in 1960 with the opening of CHA Obstetrics and Gynecology in Seoul, Korea. Since then, CHA has garnered worldwide recognition and accolades for excellence in the fields of reproductive and regenerative medicine, driven by Chairman Dr. Kwang Yul Cha. Our breakthroughs have been featured in international publications such as TIME Magazine, Wall Street Journal, and Vogue; major television networks such as NBC and BBC; medical textbooks; and scientific peer-reviewed journals. CHA owns and operates 6 hospitals and clinics throughout Korea and CHA Hollywood Presbyterian Medical Center, one of the largest private hospitals in Los Angeles. We also operate 6 CHA Fertility Centers including Asia's largest fertility clinic in Seoul and the world's first commercial egg freezing bank in southern California. Our Tokyo Cell Clinic in Japan, premier anti-aging and wellness center Chaum in Korea, and beauty brands such as CHA:LAB take advantage of our innovations in regenerative medicine. The CHA Bio Complex, founded in 2014, is one of Asia's most extensive inter-departmental biomedical campuses. Our activities also include pharmaceutical and biotech ventures such as CHA Bio & Diostech, one of the largest biotechs listed in the KOSDAQ. CHA Health Systems' collective emphasis on translational research using a multi-disciplinary, highly collaborative "bench-to-bedside" approach enables the integration of academic, research, consumer, industrial and medical fields. By focusing on our vision, CHA enriches, motivates and nourishes the community and people we serve.